Skip to main content
. 2020 Oct 30;133:104681. doi: 10.1016/j.jcv.2020.104681

Fig. 2.

Fig. 2

Assay workflow for Anti-CoV2. Specific anti-SARS-CoV-2 antibodies (red) in patient sample bind to SARS-CoV-2 antigens (orange) conjugated to fluorescent particles (green). After transfer of the sample mixture to the eStick, the antibody-conjugate complex binds to the SARS-CoV-2 antigen on the solid phase. The eStick detects the presence of SARS-CoV-2 antibodies and provides a qualitative readout to the eHub in 3–10 min.